Monoclonal antibody 93KA9Alternative Names: Human anti-VZV antibody
Latest Information Update: 09 Aug 2002
At a glance
- Originator Novartis
- Developer PDL BioPharma
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Varicella zoster virus infections
Most Recent Events
- 20 Feb 1997 New profile
- 20 Feb 1997 Preclinical development for Varicella zoster virus infections in USA (Unknown route)